To evaluate the effectiveness and safety of piribedil for the symptomatic treatment of Parkinson's disease in monotherapy or adjuvant to levodopa.
This is a protocol.
Piribedil for symptomatic management of Parkinson's disease
You may also be interested in:
- Piribedil for levodopa-induced complications in Parkinson's disease
- Piribedil versus levodopa in early Parkinson's disease
- The effect of blood pressure lowering drugs in protecting the nerve cells involved in Parkinson's disease
- The effect of anti-inflammatory drugs in protecting the nerve cells involved in Parkinson's Disease
- Therapeutic interventions for daytime somnolence in Parkinson's disease
Health topics: